CELLECT BIOTECHNOLOGY overview

...

Thinking about buying stock in Meta Materials, Cellect Biotechnology, Forte Biosciences, Camber Energy, or Denison Mines? PR Newswire NEW YORK, Sept. 3, 2021 NEW YORK , Sept. 3, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MMAT, APOP, FBRX, CEI, and DNN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. MMAT:...

Thinking about buying stock in Citius Pharmaceuticals, New Oriental Education, Cellect Biotechnology, Novan, or Seanergy Maritime? PR Newswire NEW YORK, June 17, 2021 NEW YORK , June 17, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CTXR, EDU, APOP, NOVN, and SHIP. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. CTXR:...

...

Thinking about buying stock in Cellect Biotechnology, Castor Maritime, AMC Entertainment, Immutep, or Hall of Fame Resort & Entertainment? PR Newswire NEW YORK, March 25, 2021 NEW YORK , March 25, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APOP, CTRM, AMC, IMMP, and HOFV. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. APOP:...

...

Cellect Biotechnology Reports Second Quarter Financial and Operating Results; First Half 2020 Strategic Developments Create Long-Term Revenue Catalysts PR Newswire TEL AVIV, Israel, Aug. 12, 2020 TEL AVIV, Israel , Aug. 12, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported financial and operating results for the second quarter ended June 30, 2020 . The Company's six-month...

European Patent Office Grants Cellect Biotechnology Pivotal Patent for Stem Cells Activation Strengthened Intellectual Property Portfolio Enables Acceleration of Business Development Activities PR Newswire TEL AVIV, Israel, Aug. 6, 2020 TEL AVIV, Israel , Aug. 6, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced that it has significantly strengthened its Intellectual Property...